Home › Funds › GLOBALT Investments LLC / GA › GILD

GLOBALT Investments LLC / GA position in GILD

GILEAD SCIENCES INC · Health Care

GLOBALT Investments LLC / GA reported holding 51,911 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$7.7M, representing 0.27% of its reported portfolio and ranking #47 among its reported holdings. GLOBALT Investments LLC / GA has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)51.91K sh
Reported value held$7.74M
Portfolio Weight0.27%
First reportedQ4 2023
Last changeReduce
Updated2026-10-27

Last updated: 2026-10-27 · Source: SEC EDGAR Form 13F-HR

How GLOBALT Investments LLC / GA's GILD position evolved

GLOBALT Investments LLC / GA first disclosed a stake in GILD in Q4 2023 at 43,969 shares (US$3.6M). The position peaked in Q3 2026 at 51,911 shares, worth US$7.7M. Across 12 filings, GLOBALT Investments LLC / GA increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 51,911 shares valued at US$7.7M — a reduction of -1,234 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2023 43.97K $3.56M New
Q1 2024 42.96K $3.15M Reduce
Q2 2024 42.45K $2.91M Reduce
Q3 2024 40.45K $3.39M Reduce
Q4 2024 48.66K $4.49M Add
Q1 2025 48.23K $5.40M Reduce
Q2 2025 49.42K $5.48M Add
Q3 2025 48.42K $5.37M Reduce
Q4 2025 55.50K $6.81M Add
Q1 2026 54.05K $7.53M Reduce
Q2 2026 53.15K $6.71M Reduce
Q3 2026 51.91K $7.74M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has GLOBALT Investments LLC / GA held GILD?

GLOBALT Investments LLC / GA has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is GLOBALT Investments LLC / GA's current position in GILD?

As of Q3 2026, GLOBALT Investments LLC / GA holds 51.91K shares of GILD (GILEAD SCIENCES INC), valued at $7.74M, representing 0.27% of its reported portfolio and ranking #47.

Has GLOBALT Investments LLC / GA been buying or selling GILD?

In the latest 13F filing (Q3 2026), GLOBALT Investments LLC / GA reduced its position in GILD. The position peaked in Q3 2026 at 51.91K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.